Literature DB >> 14392230

The treatment of acute infectious hepatitis. Controlled studies of the effects of diet, rest, and physical reconditioning on the acute course of the disease and on the incidence of relapses and residual abnormalities.

T C CHALMERS, R D ECKHARDT, W E REYNOLDS, J G CIGARROA, N DEANE, R W REIFENSTEIN, C W SMITH, C S DAVIDSON.   

Abstract

Entities:  

Keywords:  HEPATITIS, INFECTIOUS/therapy

Mesh:

Year:  1955        PMID: 14392230      PMCID: PMC438866          DOI: 10.1172/JCI103164

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  13 in total

1.  Clinical evaluation of a high-protein, high-carbohydrate, restricted-fat diet in the treatment of viral hepatitis.

Authors:  N C LEONE; F RATNER; W C DIEFENBACH; M G EADS; J E LIEBERMAN; R MURRAY
Journal:  Ann N Y Acad Sci       Date:  1954-05-10       Impact factor: 5.691

2.  Influence of alcohol consumption on hepatic function in healthy gainfully employed men.

Authors:  L ZIEVE; E HILL
Journal:  J Lab Clin Med       Date:  1953-11

3.  The incidence of residuals of viral hepatitis.

Authors:  L ZIEVE; E HILL; S NESBITT; B ZIEVE
Journal:  Gastroenterology       Date:  1953-12       Impact factor: 22.682

4.  Effects of Protein Diet on Infective Hepatitis.

Authors:  E M Darmady
Journal:  Br Med J       Date:  1945-06-09

5.  SEROLOGICAL DIFFERENTIATION OF OBSTRUCTIVE FROM HEPATOGENOUS JAUNDICE BY FLOCCULATION OF CEPHALIN-CHOLESTEROL EMULSIONS.

Authors:  F M Hanger
Journal:  J Clin Invest       Date:  1939-05       Impact factor: 14.808

6.  An Analysis of the Effect of Fat in the Diet on Recovery in Infectious Hepatitis.

Authors:  C L Hoagland; D H Labby; H G Kunkel; R E Shank
Journal:  Am J Public Health Nations Health       Date:  1946-11

7.  Normal and abnormal variations and clinical significance of the one-minute and total serum bilirubin determinations.

Authors:  L ZIEVE; E HILL; M HANSON; A B FALCONE; C J WATSON
Journal:  J Lab Clin Med       Date:  1951-09

8.  The syndrome of impending hepatic coma in patients with cirrhosis of the liver given certain nitrogenous substances.

Authors:  G B PHILLIPS; R SCHWARTZ; G J GABUZDA; C S DAVIDSON
Journal:  N Engl J Med       Date:  1952-08-14       Impact factor: 91.245

9.  Diet in the treatment of acute hepatitis.

Authors:  O GERTZEN
Journal:  Br Med J       Date:  1950-05-20

10.  Clinical course of viral hepatitis and the effect of exercise during convalescence.

Authors:  W E SWIFT; H T GARDNER; D J MOORE; F H STREITFELD; W P HAVENS
Journal:  Am J Med       Date:  1950-05       Impact factor: 4.965

View more
  33 in total

Review 1.  THE CONTROLLED THERAPEUTIC TRIAL IN GASTROENTEROLOGY.

Authors:  S C TRUELOVE; R WRIGHT
Journal:  Am J Dig Dis       Date:  1964-01

2.  CHRONIC PERSISTING HEPATITIS.

Authors:  J T GALAMBOS
Journal:  Am J Dig Dis       Date:  1964-11

3.  POTENTIAL USES AND LIMITATIONS OF HOSPITAL DATA IN EPIDEMIOLOGIC RESEARCH.

Authors:  A T MASI
Journal:  Am J Public Health Nations Health       Date:  1965-05

4.  Viral hepatitis and its sequelae.

Authors:  T C CHALMERS
Journal:  Am J Dig Dis       Date:  1961-02

5.  Chronic hepatitis.

Authors:  W C MACDONALD; A BOGOCH
Journal:  Can Med Assoc J       Date:  1961-05-20       Impact factor: 8.262

6.  [On the effect of hot cataplasms and bed rest on the blood supply of the human liver from a therapeutic point of view].

Authors:  L DEMLING; R GROMOTKA
Journal:  Klin Wochenschr       Date:  1960-06-15

7.  Role of rest and ambulation in liver disease; management of acute infectious hepatitis.

Authors:  M A PAYNE
Journal:  Am J Dig Dis       Date:  1958-02

8.  Diet and nutritional aids in liver disease.

Authors:  V M SBOROV
Journal:  Am J Dig Dis       Date:  1958-02

9.  Infectious hepatitis.

Authors:  B HALLIDAY
Journal:  Can Med Assoc J       Date:  1956-11-15       Impact factor: 8.262

10.  A 1955 clinical trial report that changed my career.

Authors:  David Sackett
Journal:  J R Soc Med       Date:  2010-06       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.